8.6 C
New York
Sunday, May 9, 2021

Pfizer drops its bid to bring Baxalta’s experimental anthrax vaccine to market

- Advertisement -
- Advertisement -

Pfizer on Thursday announced that it had withdrawn its application seeking authorization to market Baxalta’s experimental anthrax vaccine in the United States, citing “developing commercial considerations.”

The U.S. Food and Drug Administration had approved the Canadian company to market an early version of the vaccine for civilians, but without specifying a launch date.

The withdrawal means Baxalta, which was acquired by Pfizer for $14 billion earlier this year, will not be able to begin to sell the vaccine in the U.S. until a final decision is made by the FDA, according to Pfizer.

“While we are disappointed that we will not be able to commercially begin marketing the immunotherapy Baxalta’s experimental anthrax vaccine in the U.S., we are very pleased that Baxalta’s accelerated FDA-directed development plan is generating real value for all Baxalta stakeholders,” said Pfizer chairman and chief executive Ian Read in a statement.

Baxalta’s experimental vaccine is now a non-factor for the roughly 22,000 people in the United States at highest risk for exposure to anthrax.

- Advertisement -

Latest news

‘No question, we can do better’: How to overcome the stigma of experiencing traumatic events

A year ago on this same date, a nation was first rocked by the Department of Justice’s charge that far too many African-Americans —...
- Advertisement -

How to run a dream vacation and still save money

Been training with people to teach them how to fly without spending much time worrying about the plane falling out of the sky. What...

The Champions League Final is a long way from the Nou Camp

For the first time in its history, the UEFA Champions League final will take place at Wembley Stadium in London, instead of its traditional...

Will jobs ever return to the artisanship industry?

Paris-based luxury and lifestyle brand Hermes was careful to remind its executives that they were talking about conditions for everyone — not just employees...

Related news

‘No question, we can do better’: How to overcome the stigma of experiencing traumatic events

A year ago on this same date, a nation was first rocked by the Department of Justice’s charge that far too many African-Americans —...

How to run a dream vacation and still save money

Been training with people to teach them how to fly without spending much time worrying about the plane falling out of the sky. What...

The Champions League Final is a long way from the Nou Camp

For the first time in its history, the UEFA Champions League final will take place at Wembley Stadium in London, instead of its traditional...

Will jobs ever return to the artisanship industry?

Paris-based luxury and lifestyle brand Hermes was careful to remind its executives that they were talking about conditions for everyone — not just employees...
- Advertisement -